Optometrist · Humble, TX
NPI
1821093014
Since 2005
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
18850 S Memorial Dr
Humble, TX, 77338
Phone (713) 275-2457
Groups this clinician bills Medicare through
Medicare paid, 2024
$131K
2,461 services
Medicare patients, 2024
767
Average age 76
Drug cost, 2024
$812K
1,594 prescriptions
Company payments, 2025
$36K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruce A Krawiecki was code 92250 (angiography), 434 times for 389 patients. In total Bruce A Krawiecki billed 2,461 services in 23 codes, and Medicare paid $131K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92250 Angiography | Office | 434 | 389 | $23.92 | $10K |
| 99214 Office E&M - Established | Office | 431 | 338 | $87.94 | $38K |
| 99213 Office E&M - Established | Office | 353 | 273 | $61.08 | $22K |
| 92014 Ophthalmological E&M | Office | 294 | 270 | $78.62 | $23K |
| 92134 Computerized Ophthalmic Imaging | Office | 291 | 273 | $28.42 | $8,271 |
| 92083 Vision, Hearing, and Speech Services | Office | 251 | 211 | $44.49 | $11K |
| 92133 Computerized Ophthalmic Imaging | Office | 221 | 201 | $24.76 | $5,471 |
| 99212 Office E&M - Established | Office | 75 | 66 | $35.20 | $2,640 |
| 99204 Office E&M - New | Office | 28 | 28 | $112.48 | $3,149 |
| 92020 Ophthalmological E&M | Office | 18 | 16 | $21.60 | $389 |
| 92004 Ophthalmological E&M | Office | 16 | 16 | $76.23 | $1,220 |
| 68761 Eye | Office | 13 | 12 | $168.62 | $2,192 |
By year: 2022 $130K for 2,246 services; 2023 $141K for 2,592 services; 2024 $131K for 2,461 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bruce A Krawiecki prescribed most often to Medicare patients was Latanoprost, with 237 prescriptions and refills. In total Bruce A Krawiecki wrote 1,594 Medicare prescriptions that cost $812K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 237 | 540 | 83 | $2,307 |
| Xdemvy Lotilaner | 181 | 255 | 165 | $336K |
| Lumigan Bimatoprost | 124 | 284 | 39 | $75K |
| Restasis Cyclosporine | 89 | 184 | 46 | $113K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 89 | 195 | 24 | $1,530 |
| Prednisolone Acetate Generic | 81 | 108 | 67 | $3,921 |
| Brimonidine Tartrate Generic | 70 | 177 | 21 | $1,799 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 63 | 63 | 50 | $674 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 53 | 102 | 14 | $11K |
| Miebo Perfluorohexyloctane/Pf | 52 | 62 | 22 | $43K |
| Timolol Maleate Generic | 49 | 130 | 19 | $1,769 |
| Combigan Brimonidine Tartrate/Timolol | 42 | 69 | 15 | $14K |
| Cequa Cyclosporine | 41 | 75 | 20 | $40K |
| Alphagan P Brimonidine Tartrate | 39 | 73 | Under 11 | $17K |
| Rhopressa Netarsudil Mesylate | 30 | 42 | Under 11 | $14K |
Brand drugs: 1,070 claims; generic drugs: 524 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruce A Krawiecki $36K ($36K in general payments such as food, travel and fees) from 17 companies. The largest payer was Nordic Pharma, Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| Nordic Pharma, Inc. | 1 | $25K |
| Tarsus Pharmaceuticals, Inc. TARS | 29 | $6,359 |
| Biotissue Holdings Inc. | 11 | $1,629 |
| Abbvie Inc. ABBV | 20 | $844 |
| Alcon Vision LLC ALC | 14 | $652 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $446 |
| Carl Zeiss Meditec USA, Inc. | 5 | $267 |
| New World Medical,Inc. | 3 | $243 |
| Rayner Intraocular Lenses Limited | 2 | $233 |
| Dompe US, Inc. | 6 | $224 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.